NPYR in adipocytes appears to play an important role in PTX3- and NPY-induced stimulation of adipogenesis, implying that NPYRs might be a potential therapeutic target for the treatment of obesity. Here, NPY is linked to obesity due to melanocortin 4 receptor deficiency.